The twelfth episode of #ArthritisAtHome features Dr. Carter Thorne, Assistant Professor of Medicine, University of Toronto and Chief Division of Rheumatology at Southlake Regional Health Centre in New Market, Ontario, on hydroxychloroquine supply and how it affects patients with rheumatic diseases during #COVID19. #FactsFriday
As one of the leaders of the Canadian Rheumatology Association, Dr. Thorne has been actively consulting with Health Canada, the public drug plans and pharmaceutical companies about drug shortages affecting patients with autoimmune diseases as a result of the COVID-19 pandemic.
Dr. Thorne discusses recent challenges patients have had to access hydroxychloroquine, particularly in Quebec, and what is really going on with our drug supply and who is potentially at risk.
Visit the official page of Arthritis At Home: https://arthritisathome.jointhealth.org
Check out these helpful resources for patients:
Canadian Rheumatology Association COVID-19 Resource Centre: https://rheum.ca/covid19/
Arthritis Consumer Experts – Unintended consequences: Drug shortages during the COVID-19 pandemic: https://bit.ly/ACEJHE-HCQ
Arthritis Research Canada – Taking Care During COVID-19: https://www.arthritisresearch.ca/responding-to-covid-19/
Canadian Arthritis Patient Alliance – COVID-19: Information Resources – http://arthritispatient.ca/covid-19-information-resources/
Canadian Spondylitis Association – COVID-19 Information Center: https://www.spondylitis.ca/education/covid-19-information-center/
The Arthritis Society – COVID-19 and arthritis: https://arthritis.ca/about-arthritis/arthritis-in-the-news/news/covid-19-(coronavirus)